{"id":52390,"date":"2021-11-05T13:24:12","date_gmt":"2021-11-05T11:24:12","guid":{"rendered":"https:\/\/forklog.com\/en\/?p=52390"},"modified":"2025-09-03T09:58:41","modified_gmt":"2025-09-03T06:58:41","slug":"alphabet-launches-isomorphic-laboratories-to-pursue-ai-first-drug-discovery","status":"publish","type":"post","link":"https:\/\/u1f987.com\/en\/alphabet-launches-isomorphic-laboratories-to-pursue-ai-first-drug-discovery\/","title":{"rendered":"Alphabet launches Isomorphic Laboratories to pursue AI-first drug discovery"},"content":{"rendered":"<p>Alphabet has founded Isomorphic Laboratories, a company that uses artificial intelligence to discover new medicines. It is led by Demis Hassabis, the chief executive of the DeepMind lab.<\/p>\n<blockquote class=\"twitter-tweet\">\n<p lang=\"en\" dir=\"ltr\">Thrilled to announce the launch of a new Alphabet company <a href=\"https:\/\/twitter.com\/IsomorphicLabs?ref_src=twsrc%5Etfw\">@IsomorphicLabs<\/a>. Our mission is to reimagine the drug discovery process from first principles with an AI-first approach, to accelerate biomedical breakthroughs and find cures for diseases. Details: <a href=\"https:\/\/t.co\/WQrG36ddgZ\">https:\/\/t.co\/WQrG36ddgZ<\/a> <a href=\"https:\/\/t.co\/RRV6VeDhpL\">pic.twitter.com\/RRV6VeDhpL<\/a><\/p>\n<p>\u2014 Demis Hassabis (@demishassabis) <a href=\"https:\/\/twitter.com\/demishassabis\/status\/1456283985554939907?ref_src=twsrc%5Etfw\">November 4, 2021<\/a><\/p><\/blockquote>\n<p> <script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>According to Hassabis, their aim is to &#8220;rethink&#8221; the process of developing new medicines using an AI-first approach:<\/p>\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>&#8220;We believe that the fundamental use of advanced computing methods and artificial intelligence will help scientists take their work to a new level and significantly accelerate the drug discovery process.&#8221;<\/p>\n<\/blockquote>\n<p>Isomorphic will build models that can predict how drugs interact with the body. The lab will leverage DeepMind&#8217;s developments, including the AlphaFold 2 protein-folding prediction AI tool.<\/p>\n<p>At the same time, both labs will remain independent and will collaborate from time to time.<\/p>\n<p>Hassabis added that the company does not intend to develop its own medicines. Instead, it will focus on developing partnerships with pharmaceutical companies and selling its models.<\/p>\n<p>Earlier, DeepMind<a href=\"https:\/\/u1f987.com\/en\/news\/deepmind-ai-maps-20000-human-protein-structures\"> opened access to the database of human protein structures<\/a>, created by the AlphaFold neural network.<\/p>\n<p>In September, scientists developed<a href=\"https:\/\/u1f987.com\/en\/news\/scientists-develop-algorithm-to-identify-animal-viruses-capable-of-transmitting-to-humans\"> an algorithm for identifying viruses that could jump from animals to humans<\/a>.<\/p>\n<p>In March, NVIDIA developed an artificial intelligence,<a href=\"https:\/\/u1f987.com\/en\/news\/nvidia-develops-ai-to-speed-up-human-genome-analysis\"> accelerating the analysis of the human genome<\/a>.<\/p>\n<p>Subscribe to ForkLog News on Telegram: <a href=\"https:\/\/t.me\/forklogAI\" target=\"_blank\" rel=\"noreferrer noopener nofollow\"> ForkLog AI<\/a> \u2014 all the news from the world of AI!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alphabet has founded Isomorphic Laboratories, a company that uses artificial intelligence to discover new medicines. It is led by Demis Hassabis, the chief executive of the DeepMind lab.<\/p>\n","protected":false},"author":1,"featured_media":26216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"select":"1","news_style_id":"1","cryptorium_level":"","_short_excerpt_text":"Alphabet launches Isomorphic Laboratories to pursue AI-first drug discovery.","creation_source":"","_metatest_mainpost_news_update":false,"footnotes":""},"categories":[3],"tags":[438,738,1414],"class_list":["post-52390","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-analysis","tag-artificial-intelligence","tag-google","tag-medicine"],"aioseo_notices":[],"amp_enabled":true,"views":"31","promo_type":"1","layout_type":"1","short_excerpt":"Alphabet launches Isomorphic Laboratories to pursue AI-first drug discovery.","is_update":"","_links":{"self":[{"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/posts\/52390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/comments?post=52390"}],"version-history":[{"count":1,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/posts\/52390\/revisions"}],"predecessor-version":[{"id":52391,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/posts\/52390\/revisions\/52391"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/media\/26216"}],"wp:attachment":[{"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/media?parent=52390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/categories?post=52390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/tags?post=52390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}